Definium Therapeutics (DFTX)Chief Medical Officer sold ~$53K
Daniel Karlin, Chief Medical Officer at Definium Therapeutics, sold ~$53K of Definium Therapeutics shares.
- ~$53K
- Approx. value · 7,848 sh @ $6.80
- 438K
- Holds after · shares reported
- Traded
- Jun 25, 2025
- Filed
- Jun 26, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 25, 2025 · this disclosureInsiderOfficer sold ~$53K of DFTX shares in the open market
What came next
- Jun 25, 2025Insider · 2 peopleInsiders: 2 sales (~$258K)
- Sep 25, 2025Insider · 3 peopleInsiders: 3 sales (~$437K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Definium Therapeutics
For Definium Therapeutics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 8 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DFTX page.
Other recent filings by Daniel Karlin, Chief Medical Officer
- SEC Form 4 at Definium Therapeutics (DFTX)Sep 30, 2026
- SEC Form 4 at Definium Therapeutics (DFTX)Sep 26, 2025
- SEC Form 4 at Definium Therapeutics (DFTX)Mar 26, 2025
- SEC Form 4 at Definium Therapeutics (DFTX)Dec 27, 2024
The full history of Daniel Karlin, Chief Medical Officer is on the profile page.
How this filing works
Other disclosures at Definium Therapeutics
- SEC Form 4Sep 30, 2026
- SEC Form 4Sep 30, 2026
- SEC Form 4Sep 30, 2026
- SEC Form 4Sep 30, 2026
- SEC Form 4Sep 30, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its DFTX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data